Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > 154 days until delisting is finalized and crickets!!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(287)
•••
Comment by Renofundon Nov 02, 2022 5:55pm
82 Views
Post# 35068028

RE:RE:RE:154 days until delisting is finalized and crickets!!

RE:RE:RE:154 days until delisting is finalized and crickets!!
Bigmac4000 wrote: Because at this point I'm down 95%. Might as well go down with the ship or hope for a pathetic increase to get a little back. I'm not greedy. I'll settle for 35% back if possible.
Renofund wrote:
Bigmac4000 wrote: So 154 days until the great saviour Nasdaq delisting happens. Remember the media coverage and the millions spent. Just to get on Nasdaq cost a fortune, then the gimmicky bell ringing all at our expense and for what? What have we gained? We have a team of doctors nobody else wanted that have accomplished nothing. We have zero value, we are riding the coat tails of a failed property experiment and eventual sale just to stay in business. We have a "drug pipeline" that is slowly using up it's patent timeline i believe is 2031 or something for the Micro PIA . 154 says and no information given no media reports sent out nothing. I'd like to know something, anything


but why do you still hold it?  That makes less sense to me



yeah fair enough!

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities